focus -WSS

focus

author：explore 2025-10-02 00:53:07 - browse：9

Medical personnel wearing gloves adjust IV bags displayed on a conveyor belt. -- health policy coverage from STAT — Civica Rx is considering a move into chemotherapies amid drug shortages. Adobe

WASHINGTON — A nonprofit formed by hospitals to deal with drug shortages is considering a move into chemotherapies.

Frustrated by drug shortages and the price spikes that typically ensue, executives from large hospital systems launched the nonprofit Civica Rx to deal with the problem in September 2018. Months later, the publicly traded group purchasing organization Premier created a subsidiary, ProvideGx, with the same aim.

Although shortages are not new, the number of drugs in short supply has grown steadily for about two years. Shortages also have become more difficult to predict and are affecting drugs that are more critical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： STAT letters to the editor on burnt

WSS

Colorectal cancer study finds potential in overlooked immune cell

Was Amgen transparent enough on FDA's concern on cancer drug?

FDA needs staff influx to meet gene therapy needs, Marks says

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

A virus, fished out of a lake, may have saved a man’s life

Bill would stop addiction treatment from triggering child abuse inquiry

entertainment

focus

Wikipedia

The high cost of giving birth even with insurance

Congenital heart disease patients face new threat of heart failure

Walensky prepares to leave CDC — and Congress — behind

Chan Zuckerberg Biohub Chicago to focus on inflammation

DIEP, the 'gold standard' of breast reconstruction, is under threat

FDA panel signals lack of confidence in Amgen cancer drug data

Wildfire smoke exposes gaps in outdoor worker protections

Americans' trust in science, scientist continues decline: Report

ChatGPT in medicine: STAT answers readers' burning questions

Chemotherapy shortages won’t get better under Biden’s latest plan

focus

VC firm General Catalyst wants to buy a health system

Bristol 'take

The future of health care in the House

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

Why Charlie Gard's case is so disturbing to Americans

FDA rejects Alnylam's heart disease treatment over insufficient data

knowledge

hotspot

explore

hotspot